Effects of Extended-Release Niacin on the Postprandial Metabolism of Lp(a) and ApoB-100–Containing Lipoproteins in Statin-Treated Men With Type 2 Diabetes Mellitus
Author(s) -
Esther Ooi,
Gerald F. Watts,
Dick C. Chan,
Jing Pang,
Vijay Tenneti,
Sandra J. Hamilton,
Sally P.A. McCormick,
Santica M. Marcovina,
P. Hugh R. Barrett
Publication year - 2015
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.115.306136
Subject(s) - medicine , very low density lipoprotein , endocrinology , postprandial , apolipoprotein b , lipoprotein , chemistry , cholesterol , triglyceride , chylomicron , insulin
The effects of extended-release niacin (ERN; 1-2 g/d) on the metabolism of lipoprotein(a) (Lp(a)) and apolipoprotein (apo) B-100-containing lipoproteins were investigated in 11 statin-treated white men with type 2 diabetes mellitus in a randomized, crossover trial of 12-weeks duration.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom